Metraipolis › archive › dc_5a93016febe8
The efficacy, immunogenicity and safety of a recombinant tetrameric gE-Fc fusion protein vaccine for herpes zoster in adults 40 years of age or older:a… — Europe PMC PPR:PPR1171257
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1171257
- DOI
- 10.21203/rs.3.rs-9064014/v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T19:13:50.591Z
- SHA-256 of the archived text
e22f28f37cd922be5a03e2dd7429f5fe79ee1e2ea621bf77fe4b38f3b809087d- Stable URL of this page
https://metraipolis.com/documento/dc_5a93016febe8
How to cite
The efficacy, immunogenicity and safety of a recombinant tetrameric gE-Fc fusion protein vaccine for herpes zoster in adults 40 years of age or older:a… — Europe PMC PPR:PPR1171257 — Europe PMC, https://europepmc.org/article/PPR/PPR1171257 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a93016febe8 (Metraipolis archive dc_5a93016febe8, sha256 e22f28f37cd922be5a03e2dd7429f5fe79ee1e2ea621bf77fe4b38f3b809087d)
BibTeX
@misc{dc5a93016febe8,
title = {The efficacy, immunogenicity and safety of a recombinant tetrameric gE-Fc fusion protein vaccine for herpes zoster in adults 40 years of age or older:a… — Europe PMC PPR:PPR1171257},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1171257},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a93016febe8; sha256 e22f28f37cd922be5a03e2dd7429f5fe79ee1e2ea621bf77fe4b38f3b809087d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1171257. Agents can read the archived copy with the MCP tool read_document.